Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.316
AS - Asia 10.725
EU - Europa 9.020
SA - Sud America 1.341
AF - Africa 251
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 17
Totale 37.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.659
SG - Singapore 3.124
IT - Italia 2.586
VN - Vietnam 2.282
CN - Cina 2.273
DE - Germania 1.343
HK - Hong Kong 1.136
RU - Federazione Russa 1.096
BR - Brasile 990
SE - Svezia 816
IE - Irlanda 589
GB - Regno Unito 535
CA - Canada 513
IN - India 460
FR - Francia 389
UA - Ucraina 375
FI - Finlandia 265
ID - Indonesia 190
KR - Corea 184
AU - Australia 178
BD - Bangladesh 177
PL - Polonia 171
AT - Austria 150
ES - Italia 135
TR - Turchia 126
AR - Argentina 121
DK - Danimarca 120
NL - Olanda 120
JP - Giappone 112
IQ - Iraq 107
ZA - Sudafrica 101
MX - Messico 87
PK - Pakistan 77
BE - Belgio 60
IR - Iran 56
SA - Arabia Saudita 49
CH - Svizzera 48
PH - Filippine 48
TW - Taiwan 48
UZ - Uzbekistan 48
CO - Colombia 45
VE - Venezuela 44
PT - Portogallo 40
EC - Ecuador 38
CL - Cile 34
MY - Malesia 34
RO - Romania 32
BG - Bulgaria 26
KE - Kenya 25
LT - Lituania 25
CZ - Repubblica Ceca 24
MA - Marocco 24
EG - Egitto 23
GR - Grecia 23
IL - Israele 23
PY - Paraguay 23
JO - Giordania 22
NP - Nepal 20
ET - Etiopia 17
PE - Perù 17
TN - Tunisia 17
OM - Oman 16
UY - Uruguay 16
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
AZ - Azerbaigian 12
JM - Giamaica 12
DZ - Algeria 11
HU - Ungheria 10
KZ - Kazakistan 10
BO - Bolivia 9
PA - Panama 9
AL - Albania 8
CR - Costa Rica 8
CY - Cipro 7
HN - Honduras 7
BB - Barbados 6
PS - Palestinian Territory 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
LB - Libano 5
LY - Libia 5
MU - Mauritius 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AM - Armenia 4
EE - Estonia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MD - Moldavia 4
NG - Nigeria 4
NO - Norvegia 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BW - Botswana 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
Totale 37.798
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.912
Ashburn 1.638
Hong Kong 1.089
San Jose 1.055
Milan 1.009
Woodbridge 866
Frankfurt am Main 738
Ho Chi Minh City 692
Fairfield 670
Chandler 632
Houston 584
Dublin 569
Wilmington 567
Hanoi 530
Dearborn 370
Beijing 364
New York 363
Jacksonville 358
Santa Clara 346
Dallas 343
Los Angeles 342
Seattle 331
Cambridge 246
Toronto 235
Chicago 232
Hefei 194
Princeton 191
The Dalles 179
Nanjing 167
Melbourne 151
Council Bluffs 150
Jakarta 150
Helsinki 133
Shanghai 131
Seoul 123
Vienna 123
Lauterbourg 119
Buffalo 111
São Paulo 111
Orem 99
Moscow 91
Guangzhou 87
Warsaw 75
Da Nang 74
Kraków 74
Lawrence 72
Munich 72
Tokyo 72
Haiphong 68
Chennai 65
Rome 63
San Diego 63
Altamura 62
Dong Ket 62
Ottawa 61
London 60
Denver 58
Lachine 58
Montreal 56
Nanchang 55
Fremont 53
Brussels 52
Johannesburg 51
Monza 49
Melzo 46
Atlanta 45
Nuremberg 44
Phoenix 44
Hangzhou 43
Wayne 43
Baghdad 41
Changsha 41
Pune 41
Boardman 40
Kunming 40
Ha Long 39
Boston 38
Bắc Ninh 38
Mumbai 38
Hải Dương 37
Poplar 37
Tashkent 37
Amsterdam 36
Stockholm 36
Andover 34
Brooklyn 34
Biên Hòa 33
Shenyang 33
New Delhi 32
Turin 32
Zurich 32
Dhaka 31
Turku 31
Zhengzhou 31
Can Tho 30
Hebei 30
Thái Nguyên 30
Paris 29
Tianjin 28
Totale 23.828
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 715
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 643
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 600
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 587
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 567
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 535
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 531
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 525
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 517
A new approach for glyco-functionalization of collagen-based biomaterials 514
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 513
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 506
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 475
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 475
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 466
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 466
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 459
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 455
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 440
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 427
Phage-displayed peptides targeting specific tissues and organs 426
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 423
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 420
Nanomedicine for the treatment of Alzheimer's disease 419
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 412
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 406
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 398
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 398
Are the nanoparticles friends or foes when inhaled? 393
Enhanced brain targeting of engineered solid lipid nanoparticles 391
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 390
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 384
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 373
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 368
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 354
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 344
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 344
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 343
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 338
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 334
TrkA pathway activation induced by amyloid-beta (Abeta) 332
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 332
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 331
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 331
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 324
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 318
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 317
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 316
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 314
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 310
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 305
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 305
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 304
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 302
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 302
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 301
Effect of modified collagen on amyloid beta peptide aggregation 300
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 300
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 299
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 295
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 295
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 292
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 282
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 277
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 275
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 273
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 271
Enhanced brain targeting of engineered solid lipid nanoparticles 271
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 270
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 267
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 260
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 253
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 253
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 252
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 252
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 249
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 249
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 243
Nanotechnology for neurodegenerative disorders 243
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 240
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 239
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 239
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 237
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 236
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 236
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 235
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 234
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 232
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 230
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 228
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 228
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 227
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 227
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 225
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 217
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 216
Nanotechnology for neurodegenerative disorders 212
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 211
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 206
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 205
Totale 34.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021537 0 0 0 0 0 0 0 0 0 0 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/202615.164 2.445 987 1.230 1.650 1.851 744 2.207 862 1.276 1.443 469 0
Totale 38.803